InvestorsHub Logo
Followers 15
Posts 1610
Boards Moderated 1
Alias Born 09/07/2010

Re: None

Friday, 10/14/2011 9:55:39 AM

Friday, October 14, 2011 9:55:39 AM

Post# of 358
Depomed does have products besides Serada. This from a July 2001 PR:

Depomed, Inc. [has] one approved product on the market and another recently approved product. GraliseTM (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN). Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Inc. in the United States. The company has a robust pipeline including Serada®, which is in Phase 3 clinical development for menopausal hot flashes, as well as earlier stage candidates. Depomed formulates its products and product candidates with its proven, proprietary Acuform® drug delivery technology, which is designed to improve existing oral medications, allowing for controlled release of medications to the upper gastrointestinal tract when dosed with food.


Serada, of course, just flunked its Phase III. Hopefully, Acuform has other uses.